Vanguard Group’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,103
|
|
||||
|
2023
Q4 | $33.8K | Hold |
4,103
|
|
||||
|
2023
Q3 | $38.9K | Hold |
4,103
|
|
||||
|
2023
Q2 | $53K | Hold |
4,103
|
|
||||
|
2023
Q1 | $68.1K | Hold |
4,103
|
|
||||
|
2022
Q4 | $64.3K | Buy |
4,103
+7
|
|
||||
|
2022
Q3 | $88K | Buy |
4,096
+351
|
|
||||
|
2022
Q2 | $42K | Sell |
3,745
-6,576
|
|
||||
|
2022
Q1 | $197K | Hold |
10,321
|
|
||||
|
2021
Q4 | $210K | Sell |
10,321
-14
|
|
||||
|
2021
Q3 | $386K | Buy |
10,335
+119
|
|
||||
|
2021
Q2 | $531K | Buy |
10,216
+6,576
|
|
||||
|
2021
Q1 | $217K | Buy |
3,640
+805
|
|
||||
|
2020
Q4 | $186K | Buy |
2,835
+917
|
|
||||
|
2020
Q3 | $190K | Hold |
1,918
|
|
||||
|
2020
Q2 | $352K | Hold |
1,918
|
|
||||
|
2020
Q1 | $268K | Buy |
1,918
+1,715
|
|
||||
|
2019
Q4 | $24K | Sell |
203
-702
|
|
||||
|
2019
Q3 | $146K | Sell |
905
-65
|
|
||||
|
2019
Q2 | $746K | Buy |
970
+181
|
|
||||
|
2019
Q1 | $842K | Buy |
789
+183
|
|
||||
|
2018
Q4 | $487K | Buy |
606
+486
|
|
||||
|
2018
Q3 | $90K | Buy |
120
+13
|
|
||||
|
2018
Q2 | $418K | Hold |
107
|
|
||||
|
2018
Q1 | $404K | Buy |
107
+3
|
|
||||
|
2017
Q4 | $494K | Sell |
104
-27
|
|
||||
|
2017
Q3 | $827K | Sell |
131
-54
|
|
||||
|
2017
Q2 | $1.26M | Sell |
185
-12
|
|
||||
|
2017
Q1 | $2.33M | Buy |
197
+5
|
|
||||
|
2016
Q4 | $2.77M | Buy |
192
+18
|
|
||||
|
2016
Q3 | $3.69M | Buy |
174
+16
|
|
||||
|
2016
Q2 | $3.11M | Buy |
158
+74
|
|
||||
|
2016
Q1 | $1.45M | Buy |
84
+75
|
|
||||
|
2015
Q4 | $149K | Buy |
+9
|
|